Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1664700 | 0.77 | — | — | |
| SCHEMBL28572221 | 0.69 | MGLL (0.42) | MGLLGSK3AGSK3BFAAHGMNN | |
| SCHEMBL1389139 | 0.69 | — | — | |
| SCHEMBL5457531 | 0.65 | ALDH1A1 (0.46) | GSK3BALDH1A1MAPTNPSR1 | |
| SCHEMBL28379307 | 0.65 | — | — | |
| SCHEMBL9777831 | 0.65 | — | — | |
| SCHEMBL22916701 | 0.64 | GMNN (0.30) | MGLLGMNNALDH1A1LMNAMAPT | |
| SCHEMBL15577150 | 0.63 | MGLL (0.38) | MGLLGSK3AGSK3BFAAHGMNN | |
| SCHEMBL4978013 | 0.62 | GAA (0.31) | MGLLGSK3AGSK3B | |
| Butadiene SCHEMBL11308511 | 0.62 | MGLL (0.42) | MGLLGSK3AGSK3BFAAHGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024067295-A1 | MODIFIED RED BLOOD CELL AND USE THEREOF FOR DELIVERING MEDICAMENT | 西湖生物医药科技(杭州)有限公司 | 2024-04-04 | — | — | WO | claimed |
| EP-1590373-B1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | SANOFI PASTEUR (FR) | 2011-08-17 | — | — | EP | claimed |
| EP-1590373-A1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | Sanofi Pasteur (FR) | 2005-11-02 | — | — | EP | claimed |
| WO-2004067574-A1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | SANOFI PASTEUR (FR) | 2004-08-12 | — | — | WO | claimed |
| WO-2024067295-A1 | MODIFIED RED BLOOD CELL AND USE THEREOF FOR DELIVERING MEDICAMENT | 西湖生物医药科技(杭州)有限公司 | 2024-04-04 | — | — | WO | disclosed |
| EP-1590373-B1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | SANOFI PASTEUR (FR) | 2011-08-17 | — | — | EP | disclosed |
| EP-1590373-A1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | Sanofi Pasteur (FR) | 2005-11-02 | — | — | EP | disclosed |
| WO-2004067574-A1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | SANOFI PASTEUR (FR) | 2004-08-12 | — | — | WO | disclosed |
| US-6361777-B1 | COVALENTLY COUPLING POLYSACCHARIDE TO BIOPOLYMER HAVING HYDROXYL, AMINO AND/OR MERCAPTO GROUPS BY ACTIVATING POLYSACCHARIDE WITH CYANOGEN BROMIDE, THIOLATING WITH AMINOTHIOL LINKER, REACTING WITH BIOPOLYMER | DE STAAT DER NEDERLANDEN,VERTEGENWOORDIGD DOOR DE MINISTER VAN WELZIJN, VOLKSGEZONDHEID EN CULTUUR (NL) | 2002-03-26 | — | — | US | disclosed |
| EP-1163273-A1 | METHOD FOR THE REDUCTIVE ANIMATION OF POLYSACCHARIDES | Aventis Pasteur (FR) | 2001-12-19 | — | — | EP | disclosed |
| EP-0848011-B1 | Method of coupling polysaccharides to proteins | NEDERLANDEN STAAT (NL) | 2001-03-21 | — | — | EP | disclosed |
| WO-2000055210-A1 | METHOD FOR THE REDUCTIVE AMINATION OF POLYSACCHARIDES | AVENTIS PASTEUR (FR) | 2000-09-21 | — | — | WO | disclosed |
| EP-1035137-A1 | Method for the reductive amination of polysaccharides | PASTEUR MERIEUX SERUMS ET VACCINS (FR) | 2000-09-13 | — | — | EP | disclosed |
| WO-1998027107-A1 | METHOD OF COUPLING POLYSACCHARIDES TO PROTEINS | DE STAAT DER NEDERLANDEN, VERTEGENWOORDIGD DOOR DE MINISTER VAN WELZIJN, VOLKSGEZONDHEID EN CULTUUR (NL) | 1998-06-25 | — | — | WO | disclosed |
| EP-0848011-A1 | Method of coupling polysaccharides to proteins | DE STAAT DER NEDERLANDEN VERTEGENWOORDIGD DOOR DE MINISTER VAN WELZIJN, VOLKSGEZONDHEID EN CULTUUR (NL) | 1998-06-17 | — | — | EP | disclosed |
| US-4855468-A | Titanocenes and a radiation-polymerizable composition containing these titanocenes | CIBA-GEIGY CORPORATION (US) | 1989-08-08 | — | — | US | disclosed |
| US-4713401-A | PHOTOINITIATORS ORTHO-CF2Z GROUP | CIBA SPECIALTY CHEMICALS CORPORATION | 1987-12-15 | — | — | US | disclosed |